Brain-resident microglia may promote tissue repair following stroke but, like other cells, they are vulnerable to ischemia. Here we identify mechanisms involved in microglial ischemic vulnerability. Using time-lapse imaging of cultured BV2 microglia, we show that simulated ischemia (oxygen-glucose deprivation; OGD) induces BV2 microglial cell death. Removal of extracellular Ca 2þ or application of Brilliant Blue G (BBG), a potent P2X7 receptor (P2X7R) antagonist, protected BV2 microglia from death.
Introduction
Ischemia remains a global health concern, occurring frequently in the elderly as well as in the pre-term and term infant (Nelson, 2007) . Research focused on delineating mechanisms of neuronal death and protection has yielded potential targets for therapeutic intervention. Unfortunately, this has not yet translated into successful clinical trials (Ginsberg, 2008) . Consequently, glial-based strategies have been proposed to compliment neurocentric approaches (Nedergaard and Dirnagl, 2005; Weinstein et al., 2010; Barreto et al., 2011) . However, while the effects of ischemia on astrocytes and oligodendrocytes are being elucidated (Matute et al., 2006; Takano et al., 2009) , much less is known about how ischemia affects microglia, the resident immune cells of the CNS.
Debate persists concerning the role of microglia during ischemia. Although some studies suggest that microglia are neurotoxic during ischemia (Yrjanheikki et al., 1998; Wu et al., 2012) , there is also considerable evidence for neuroprotective roles for microglia in rodent models of stroke. For example, microglial depletion during ischemia in neonates (Faustino et al., 2011) or adults (Lalancette-Hebert et al., 2007) results in poorer outcomes. Furthermore, introduction of exogenous microglia either before (Hayashi et al., 2006; Kitamura et al., 2004 Kitamura et al., , 2005 or after (Neumann et al., 2006; Imai et al., 2007; Narantuya et al., 2010) experimental stroke reduced neurodamage, suggesting that microglia can promote recovery from stroke. Despite this neuroprotective potential of microglia following stroke, previous studies in in vitro cell culture (Lyons and Kettenmann, 1998; Yenari and Giffard, 2001 ) and acute tissue slices (Eyo and Dailey, 2012) showed that microglia themselves are susceptible to ischemic injury. However, the mechanisms involved in this susceptibility have not been identified.
Studies in astrocytes and oligodendrocytes suggest that calcium dysregulation may contribute to ischemia-induced glial cell death. Metabolic failure in the brain results in extracellular accumulation of neurotransmitters, including glutamate, which activate ionotropic receptors, leading to abnormally high calcium influx. High cytosolic calcium levels, in turn, activate proteases and initiate cell demise (Alberdi et al., 2005; Matute et al., 2006; Szydlowska and Tymianski, 2010) . However, it is unknown whether calcium dysregulation mediates ischemia-induced death of microglia, which in the 'resting' or 'surveillant' state may lack receptors for classical neurotransmitters.
Receptors for non-classical neurotransmitters, including adenosine triphosphate (ATP), are expressed by microglia and may contribute to ischemic cytotoxicity. In addition to its well-known role as an intracellular energy source, ATP also functions as an extracellular signaling molecule by activating membrane bound receptors including ionotropic P2X receptors and G-protein coupled metabotropic P2Y receptors (Burnstock, 2007) . During ischemia, ATP outflow from cells increases in vivo (Melani et al., 2005 (Melani et al., , 2012 , in ex vivo brain slices (Frenguelli et al., 2007) , and in in vitro cell culture (Liu et al., 2008; Domercq et al., 2010) . Because high levels of extracellular ATP may activate P2X7 receptors (P2X7Rs), leading to calcium influx and cytotoxicity (Skaper, 2011) , they are a candidate for mediating microglial cell death during ischemia. Indeed, P2X7Rs are predominantly expressed by immune cells, and several studies have shown that high levels of ATP induce macrophage and microglial cell death in dissociated cell cultures (Ferrari et al., 1997 (Ferrari et al., , 1999 Hanley et al., 2012) and in living tissues (Ryu et al., 2002; Jeong et al., 2010 ). Therefore, we tested the hypothesis that P2X7R signaling during oxygen and glucose deprivation (OGD), a model for ischemia, is detrimental to microglial survival.
Materials and Methods

BV2 cell culture, imaging, and cell death analysis
BV2 cells were maintained in tissue culture dishes in high glucose Dulbecco's Modified Eagle's Medium (DMEM; Gibco) supplemented with 10% heat-inactivated Fetal Bovine Serum (FBS; HyClone), 100 U/mL penicillin, and 100 mg/mL streptomycin (Gibco) in a 37 C CO 2 incubator. BV2 cells were imaged within 12e72 h of plating by modified Hoffman modulation contrast on a Leica DM-IL inverted microscope with stage heating. Images were captured every 3 min using a 20X/0.7 objective lens. Cell death was determined in time-lapse movies by a sudden change in cell morphology (blebbing or crenulation) followed by absence of cell movement for the duration of imaging. Cell death was further confirmed by labeling with Sytox (1:10,000; Invitrogen) at the end of time-lapse sequences (n ¼ 24 cells; 3 sequences).
Animals and preparation of tissue slices
For all tissue slice experiments, we used both male and female heterozygous GFP reporter mice (CX3CR1 GFP/þ ) expressing GFP under control of the fractalkine receptor (CX3CR1) promoter (Jung et al., 2000; Jackson Labs) . For some experiments, P2X7-null mice (Solle et al., 2001 ; Jackson Labs) were crossed with GFP-expressing mice to produce P2X7 À/þ :CX3CR1 GFP/þ and P2X7 À/À :CX3CR1 GFP/þ siblings. Animals were used in accordance with institutional guidelines, as approved by the animal care and use committee. All efforts were made to minimize animal suffering, to reduce the number of animals used, and to utilize cell culture and ex vivo tissue slice alternatives to in vivo techniques.
Acutely isolated hippocampal slices were prepared from neonatal (P4eP7) mice as detailed previously (Eyo and Dailey, 2012) . Briefly, mice were swiftly decapitated, and brains were removed and placed in ice-cold artificial cerebrospinal fluid (ACSF) with the following composition (in mM): NaCl, 124; KCl, 3; NaH 2 PO 4 , 1.3; MgCl 2 , 3; HEPES, 10; CaCl 2 , 3; glucose, 10. Excised hippocampi were cut transversely (400 mm thick) using a manual tissue chopper (Stoelting). Slices were maintained in HEPESbuffered ACSF.
Oxygen-glucose deprivation (OGD)
OGD was performed as described previously (Eyo and Dailey, 2012) . Briefly, OGD medium was prepared by replacing glucose with sucrose in the ACSF, then 5 mL of ACSF was bubbled with N 2 for 15 min. In all tissue slice experiments, either Sytox Orange (Molecular Probes, #S11368) or Topro-3 (Molecular Probes, #T3605) was added to ACSF at 1:10,000 (DMSO concentration at 0.0001%) before N 2 bubbling. The media was warmed briefly in a 37 C water bath and immediately applied to previously mounted slices, and the chamber was sealed and prepared for imaging.
Time-lapse confocal imaging in hippocampal slices
Confocal time-lapse imaging in tissue slices was performed on a Leica SP5 MP confocal/multiphoton imaging system with a xyz motorized stage on an upright platform, as described previously (Eyo and Dailey, 2012) . Images were taken with a 20X/0.7 Plan Apo objective lens at a resolution of 1.4 pixels/mm. Stacks of 15 confocal images taken 3 mm apart were collected at 10 min intervals. Image stacks included the surface of the slice to control for any migration of microglia to the slice surface. Image stacks were collected every 10 min in order to capture all cell death events (concomitant loss of GFP and gain of Sytox) and to clearly distinguish them from phagocytic uptake of neighboring dead cell nuclei. Multisite imaging enabled concurrent imaging of up to 8 slices with different genotypes (e.g., P2X7Het and P2X7KO). Imaging sessions typically commenced about 20e30 min after tissue slicing and lasted several hours. Illumination and image capturing parameters were set such that there was no appreciable photobleaching of the GFP signal in any of the time-lapse imaging experiments, either during control or experimental conditions.
Drugs were added to glucose-free ACSF prior to N 2 bubbling and were applied to slices throughout imaging. Apyrase (Sigma-Aldrich, no. A6132), a potato enzyme that has both adenosine 5 0 -diphosphatase and triphosphatase activity, was used at 200 U/mL in ACSF. Brilliant Blue G (BBG, Sigma-Aldrich, no. B5133) was initially dissolved in nanopure water and further diluted in ACSF to a working concentration of 1 mM. In tissue slices, microglial cell death events were identified by concomitant loss of GFP and gain of Sytox Orange (Eyo and Dailey, 2012) . For all experimental conditions, we confirmed that the pH was at w7.4 both before and after imaging.
For image processing, confocal images were collected and collated using Leica LAS AF software. Image stacks were assembled using Leica LAS AF software or ImageJ (Wayne Rasband, NIH). All images were processed using the "Smooth" filter (3 Â 3 pixel array) in ImageJ to reduce noise. In all cases, comparisons were made on images processed identically. All movies generated represent the same z-tissue depth.
Whole-cell patch clamp recording of microglia in neonatal hippocampal slices
Coronal brain slices (300 mm) were prepared from P4eP7 neonatal mice, as described previously (Wu et al., 2007) . Hippocampal slices were transferred to a recovery chamber with oxygenated (95% O 2 and 5% CO 2 ) ACSF solution containing (in mM): NaCl, 124; NaHCO 3 , 25; KCl, 2.5; KH 2 PO 4 , 1; CaCl 2 , 2; MgSO 4 , 2; glucose, 10; 300e310 mOsmol at room temperature. For divalent-free ACSF, both CaCl 2 and MgSO 4 were omitted and the osmolarity was adjusted with sucrose to 300e 310 mOsmol. Brain slices were then transferred to a recording chamber and perfused with oxygenated ACSF at 3e4 ml/min at room temperature. All recordings were performed within 3 h after mice were sacrificed. Recording pipette (5e6 MU)
120; NaCl, 5; MgCl 2 1; EGTA, 0.5; Mg-ATP, 2; Na 3 GTP, 0.1; HEPES, 10; pH 7.2; 280e 300 mOsmol. When using Cs þ -based internal solution (Cs þ IS), K-gluconate was replaced by equimolar CsMeSO 3 . The membrane potential was held at À60 mV throughout all experiments. Benzoyl-ATP (BzATP, Sigma-Aldrich, no. B6396) was used at 300 mM or 50 mM, and BBG was used at 5 mM to block BzATP-induced currents. Data were amplified and filtered at 2 kHz by a patch-clamp amplifier (Multiclamp 700B), digitalized (DIGIDATA 1440A), stored, and analyzed by pCLAMP (Molecular Devices, Union City, CA). Data were discarded when the input resistance changed >20% during recording.
Microglial cell density analysis
Microglia in hippocampal area CA1 were manually counted in confocal image stacks (15 images at 3 mm z-step size) obtained from heterozygous GFP-reporter mice. The volume of tissue sampled was calculated by measuring the 2D surface area of CA1 in ImageJ (Wayne Rasband, NIH) and multiplying this by the depth of the image stack (45 mm). The density of microglia was then calculated as: Number of microglia/Volume of tissue.
Statistical analysis
For BV2 experiments, 5e7 experiments were performed for each condition. For confocal analysis in tissue slices, data from at least 28 slices and at least 3 animals were pooled and analyzed for each condition. All results are reported as mean AE standard deviation of the population. Statistical significance was assessed using Student's t test.
Results
OGD induces BV2 microglia cell death in a calcium-and P2X7-dependent manner
Oxygen and glucose deprivation (OGD) induces microglial cell death in rodent cell cultures (Lyons and Kettenmann, 1998; Yenari and Giffard, 2001 ). To determine the mechanisms involved in OGDinduced microglial cell death, we monitored the viability of BV2 microglia during OGD by time-lapse microscopy. BV2 cell death was evident as an initial cell blebbing or crenulation, followed by cell shrinkage and a persistent lack of movement ( Fig. 1A and Movie 1). These features also correlated with uptake of a membraneimpermeable fluorescent DNA-binding dye, Sytox, which labels nuclei of cells with compromised membranes but not living cells (Fig. 1B and Movie 2) . Quantification showed that 6 h of OGD significantly increased BV2 cell death from 4.94 AE 5.25% to 22.49 AE 8.01% (Fig. 1C) . Since calcium dysregulation can mediate glial-cell death (Alberdi et al., 2005) , we investigated the role of calcium in OGD-induced BV2 cell death. Removal of calcium during OGD substantially reduced cell death to 2.94 AE 2.57% (Fig. 1C) . BV2 cells express ionotropic P2X7 receptors (Brautigam et al., 2005) , which may facilitate calcium influx and induce cell death (Raouf et al., 2007) . Indeed, we found that antagonism of P2X7Rs by Brilliant Blue G (BBG; 1 mM) significantly reduced OGD-induced BV2 cell death to 8.21 AE 6.21% (Fig. 1C) . These results indicate that calcium influx and P2X7R activation promote BV2 microglia cell death during OGD.
Supplementary data related to this article can be found online at http://dx.doi.org/10.1016/j.neuropharm.2013.05.032.
OGD induces calcium-and purine-dependent microglial cell death in neonatal mouse hippocampal slices
Although we recently demonstrated that OGD induces microglial cell death in neonatal mouse brain tissue slices (Eyo and Dailey, 2012) , the mechanisms of microglial cell death in tissues have not been studied previously. We quantified microglial cell death using dual-channel confocal time-lapse imaging in acute hippocampal slices from heterozygous CX3CR1 GFP/þ mice with GFPexpressing microglia in the presence of Sytox. Microglial cell death in slices was quantified by a concomitant loss of GFP and gain of Sytox during 6 h of imaging, as described previously (Eyo and Dailey, 2012) . Invariably, rapid loss of GFP was closely followed by gain of Sytox (or ToPro3) ( Fig. 2 and Movie 3). This rapid loss of GFP Fig. 3A, E) . However, during OGD, microglial cell death was significantly increased (38.5 AE 11.6% of microglia; 32 slices; Fig. 3B, E) , although calcium omission prevented OGDinduced microglial cell death (0.9 AE 1.1%; 31 slices; Fig. 3C , E and Movie 4). Analysis of fixed tissue slices 6 h after treatment indicated that, in the absence of OGD, calcium-free medium itself did not alter the density of GFP þ microglial cells (6.8 AE 1.1 Â 10 À6 microglia/mm 3 ; n ¼ 9 slices) relative to control (7.3 AE 0.9 Â 10 À6 microglia/mm 3 ; n ¼ 8 slices; P ¼ 0.41), consistent with there being very little baseline microglial cell death irrespective of the presence or absence of extracellular calcium.
Since OGD increases extracellular ATP ([ATP]e) in hippocampal slices (Juranyi et al., 1999; Frenguelli et al., 2007) , and high [ATP]e can be cytotoxic to microglia (Ferrari et al., 1997) , we speculated that degradation of [ATP]e would inhibit OGD-induced microglial cell death. Indeed, apyrase (200 U/mL), an ATP/ADP degrading enzyme, prevented OGD-induced microglial cell death (0.0005 AE 0.003% of microglia; 26 slices; Fig. 3D, E) . Together, these results indicate that OGD induces death of parenchymal microglia in neonatal slices through a calcium-and purine-dependent mechanism.
Expression of functional P2X7R in microglia in neonatal hippocampus
Although BV2 cells express P2X7Rs (Brautigam et al., 2005) and OGD-induced BV2 cell death was abolished by a P2X7R antagonist (Fig. 1) , it is unknown whether parenchymal microglia in the neonatal hippocampus express functional P2X7Rs. Thus, we performed whole-cell patch clamp recordings in GFP-expressing microglia in the CA1 stratum radiatum (SR) of freshly isolated neonatal hippocampal slices (Fig. 4A) . At a holding potential of À60 mV and normal K þ -based internal solution (IS), local puff application of a potent P2X7R agonist, benzoyl-ATP (BzATP, 300 mM, 1 s or 5 s), induced a rapid small inward current followed by a substantial outward current (Fig. 4B) . Consistent with our previous study (Wu et al., 2007) , when intracellular K þ was replaced by Cs þ , BzATP induced a small inward current but no outward current (Fig. 4B ).
As expected for P2X7R currents, we found that BzATP (300 mM, 1 s) induced substantially larger inward currents (397.1 AE 68.2 pA, n ¼ 6) when divalent cation-free ACSF was used. There was no significant increase in the BzATP current (402.6 AE 38.8 pA; n ¼ 6) when the duration of puff application was increased to 5 s (Fig. 4B Fig. 4C, E ; n ¼ 5). Voltage ramp test (from À120 mV to þ100 mV, 200 ms) showed a reversal potential of the BzATP-induced inward currents at around 0 mV (n ¼ 8). BBG (5 mM) inhibited the current but did not change its reversal . E, Quantitative analysis shows a significant increase in microglial cell death during OGD that is abolished by removal of extracellular calcium or application of apyrase. ***P < 0.005 relative to OGD. potential (n ¼ 5) (Fig. 4D) . These results suggest that microglia express functional P2X7Rs in freshly prepared neonatal mouse hippocampal slices, as they do in adult mouse hippocampus (Avignone et al., 2008) .
Pharmacological modulation of P2X7R alters OGD-Induced microglial cell death in neonatal brain slices
Having detected functional P2X7Rs in tissue microglia, we proceeded to test the hypothesis that P2X7Rs are involved in OGDinduced microglial cell death in brain tissues. To do this, we first employed a pharmacological approach. Application of BBG (1 mM) during OGD significantly reduced microglial cell death from 37.9 AE 11.4% (n ¼ 28 slices) to 26.3 AE 13.1% (n ¼ 28 slices; Fig. 5 ). Under non-OGD conditions, the density of GFP þ microglia was not significantly different between control slices (6.8 AE 1.1 Â 10 À6 microglia/mm 3 ; n ¼ 8 slices) and BBG-treated slices (5.8 AE 1.6 Â 10 À6 microglia/mm 3 ; n ¼ 8 slices; P ¼ 0.15), indicating that BBG itself is not toxic and does not alter basal levels of microglial cell survival. These pharmacological data are consistent with the idea that P2X7R activation promotes OGD-induced microglial cell death.
Knockout of P2X7 receptor significantly reduces OGD-Induced microglial cell death
Since pharmacological reagents may not be entirely specific, we extended our studies with a genetic approach using P2X7R null mice. To visualize microglia, we crossed P2X7R null mice with GFP-reporter mice. There were no obvious differences in the morphology or distribution of microglia in hippocampal slices freshly isolated from P2X7R knockout (P2X7KO) and P2X7R heterozygous (P2X7Het) neonatal mice (Fig. 6A, B) . Moreover, quantitative analyses of initial microglial density in hippocampal slices at the start of imaging showed no significant difference between P2X7RHet (10.3 AE 1.6 Â 10 À6 microglia/mm 3 ; n ¼ 17 slices; 3 mice) and P2X7RKO (9.6 AE 1.4 Â 10 À6 microglia/mm 3 ; n ¼ 19 slices; 3 mice) (Fig. 6C) .
To directly compare OGD-induced microglial cell death in P2X7RKO and P2X7RHet tissues, hippocampal slices from littermate P2X7KO and P2X7Het neonatal mice were imaged simultaneously by multisite imaging. OGD-induced microglia cell death at 6 h was extensive in all hippocampal areas in P2X7RHet slices (Fig. 6A 0 ) but not in the P2X7RKO slices (Fig. 6B 0 ) . Quantitative analyses (18 slices from 3 animals for each genotype) showed that microglial cell death was reduced to nearly half (57%) in the P2X7RKO (21.0 AE 11.8%) relative to the P2X7RHet (36.4 AE 8.9%) (Fig. 6D) . Movie 5 shows a representative comparison of microglial cell death in P2X7RHet and P2X7RKO slices. Thus, genetic deletion of P2X7R protected tissue microglia from cell death during OGD. Taken together, our results using both pharmacological and genetic approaches demonstrate that P2X7Rs regulate OGD-induced microglial cell death in neonatal brain tissues.
Discussion
Our previous work using time-resolved imaging in live brain slices demonstrated that OGD rapidly inhibits microglial motility and induces microglial cell death (Eyo and Dailey, 2012) . Here, we extend those findings to show that OGD-induced microglial cell death in cell culture and in tissue slices is dependent on extracellular calcium and is regulated by purinergic signaling. Our electrophysiological data demonstrate that microglia in acutely excised neonatal brain slices express functional P2X7 receptors, and both pharmacological and genetic approaches indicate that P2X7R activation contributes to OGD-induced microglial cell death. This is the first demonstration of a specific purinergic receptor regulating microglial cell survival in brain tissues. Given the mechanistic similarities in tissue slices and BV2 cell cultures, microglial cell death during OGD may occur cell autonomously in situ as it does in cell culture.
Neonatal hippocampal microglia express functional P2X7Rs
Previous studies have shown that cultured microglia express P2X7 receptors (Ferrari et al., 1996 (Ferrari et al., , 1997 Di Virgilio et al., 1999) . However, activation of microglia during the process of isolation and culturing may induce or upregulate receptor expression. Earlier work in brain slices from neonatal mouse white matter (Haas et al., 1996) and adult forebrain (Bousein et al., 2003) support the idea that microglia express functional P2X7Rs in tissues. However, the identity of the receptor(s) mediating such currents was not definitively resolved because the agonists (ATP and BzATP) used in those studies may activate other P2 receptors (North, 2002) , and neither study presented evidence for blockade of BzATP/ATP-induced currents by selective P2X7R antagonists. A more recent study showed BBG (3 mM)-sensitive, P2X7R-like currents in identified microglia in adult mouse hippocampal slices, and observed an increase in both P2X7 mRNA and BBG-sensitive currents in slices harvested 24 h but not 3 h after kainate-induced status epilepticus in vivo (Avignone et al., 2008) . Here, we provide additional support for expression of functional P2X7Rs in microglia in the neonatal mouse hippocampus using a P2X7R agonist, BzATP (50 mM), to elicit current responses that are inhibited by a selective P2X7R antagonist, BBG (Fig. 4) . These reagents are widely recognized to target P2X7Rs (Jiang et al., 2000; Friedle et al., 2010) . A recent study of microglia in embryonic mouse spinal cord tissues likewise showed that high [ATP]e induces BBG-sensitive currents that are absent in P2X7R nulls (Rigato et al., 2012) . Together, these data indicate that both embryonic and early postnatal microglia express functional P2X7Rs.
The normal physiological roles of the P2X7 receptor during neonatal development remain to be determined. P2X7 receptor signaling has been suggested to regulate phagocytosis (Gu et al., 2011) and microglial proliferation (Rigato et al., 2012) . Although we have not tested the role of this receptor in microglial phagocytosis in situ, our observations in the early postnatal hippocampus failed to detect any difference in microglial cell density between P2X7R heterozygote and knockout littermates (Fig. 6C) , suggesting that P2X7R does not contribute significantly to microglia colonization or proliferation during neonatal hippocampal development.
ATP-and P2X7R-dependent cytotoxicity during stroke
The function of P2X7R during brain ischemia has been controversial. Le Feuvre et al. (2003) reported similar infarct volumes in wild type and P2X7R null mice 24 h after transient or permanent ischemia, suggesting that P2X7Rs are not primary mediators of neuronal cell death during early post-ischemic periods. However, more recent studies using selective pharmacological reagents have demonstrated that P2X7R inhibition protects oligodendrocytes (Domercq et al., 2010) and neurons (Arbeloa et al., 2012) in vivo when assessed 3e7 d following ischemia. These studies indicate that P2X7R activation promotes death of oligodendrocytes and neurons after stroke in vivo. Our results here suggest that P2X7R activation also contributes to death of microglia. Although our study focuses on the first few hours during OGD and are most relevant to the early stages of ischemic injury, our data do not exclude the possibility that P2X7Rs also regulate activation of microglia and neuroinflammation at later post-ischemic stages (Yanagisawa et al., 2008; Chu et al., 2012) . Given the evidence that microglia promote tissue repair following ischemia (LalancetteHebert et al., 2007; Narantuya et al., 2010; Faustino et al., 2011) , our results imply that enhancing microglial survival during ischemia by antagonizing P2X7R activation could enhance tissue recovery after stroke.
Mechanisms of microglial cell death during OGD
The mechanisms of P2X7-mediated microglial cell death during OGD have not been fully established but likely involve ATP-receptor activation and calcium influx within microglia. Previous studies have shown that extracellular ATP levels increase after OGD in hippocampal slices (Juranyi et al., 1999; Frenguelli et al., 2007) and during stroke in vivo (Melani et al., 2012) . High [ATP]e can activate P2X7 receptors, resulting in increased membrane permeability to calcium and cell death (Ferrari et al., 1997; Raouf et al., 2007; Skaper, 2011) . Our finding that OGD-induced death of BV2 cells in culture and parenchymal microglia in slices is dependent on extracellular calcium is consistent with P2X7R-mediated calcium influx. However, while OGD-induced cytotoxic calcium influx may occur via P2X7R channel opening or large pore formation, other calcium permeation pathways involving channel proteins such as pannexins also may be involved (Pelegrín, 2011) .
Calcium removal during OGD virtually abolished death of both BV2 cells in culture and parenchymal microglia in acute brain slices. However, P2X7 receptors are only partial contributors to ischemic microglial cell death because, unlike calcium removal, both pharmacological inhibition (in cell culture and acute slices) and genetic deletion of P2X7 receptors did not completely protect microglia from ischemia-induced cell death (compare Fig. 3 with Figs. 5 and 6). This suggests involvement of other calcium-regulating mechanisms that remain to be identified.
OGD induced a P2X7R-dependent death of cultured BV2 cells in the absence of other cell types, suggesting an autocrine-based mechanism of ATP release and receptor activation. Because the mechanisms of OGD-induced cell death in dissociated cell culture and tissue slices appear similar, cell autonomous mechanisms may be sufficient to cause death of microglia in situ. However, in tissue settings, astrocytes and other cell types may contribute to ATPmediated cell death. There is evidence that rodent astrocytes express P2X7R-like currents in cell culture (Duan et al., 2003; Nörenberg et al., 2010) and in brain slices (Oliveira et al., 2011) , although another study using three different electrophysiological approaches failed to detect functional P2X7Rs on astrocytes in postnatal (P9-18) hippocampal slices using a similar concentration of BzATP (20 mM) to ours (50 mM) (Jabs et al., 2007) . This latter study found that, unlike astrocytes, microglia in these slice preparations express functional P2X receptors, although the specific subtype(s) were not identified. Given our identification of functional P2X7Rs on microglia in situ, these data suggest that the cellular site of detrimental P2X7R activation in hippocampal slices during OGD is more likely microglia than astrocytes, further strengthening the case for cell autonomous mechanisms. However, at present we cannot rule out that, in tissue settings, a variety of cell types may contribute to ATP outflow leading to death of microglia.
Conclusion
In summary, using both pharmacological and genetic approaches, we provide evidence for calcium-dependent and P2X7R-mediated microglial cell death during OGD in brain tissues. Results from isolated cell culture studies suggest that OGD-induced microglial cell death may occur cell autonomously, and that P2X7R-dependent mechanisms operate (at least in part) within microglia. However, P2X7Rs are not the sole contributors to the purine-and calcium-dependent ischemic cell death, and other mechanisms remain to be discovered. Although future studies will have to be conducted to determine the relevance of these mechanisms to stroke in vivo, these results provide insights that may be directed toward developing therapies for recovery after stroke. Viewed more broadly, this is the first study to identify a purinergic receptor regulating microglial cell death in living brain tissues under any conditions and thus has significance for developing therapeutic strategies for protecting microglia at times when they may be beneficial, or potentially promoting microglial cell death when they are cytotoxic.
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